Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Hiroaki, Sakurada"'
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 49(1)
We performed a study on the ratio of anti-cancer drug purchase costs at municipal hospitals in Aichi using meeting materials from the 2020 Aichi Prefectural Public Hospital Pharmacy Directors' Association. The ratio of anti-cancer drug purchase costs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cba7bd0f115d1be7382e0ef9e772ac92
https://pubmed.ncbi.nlm.nih.gov/35046362
https://pubmed.ncbi.nlm.nih.gov/35046362
Publikováno v:
Electronics; Volume 11; Issue 19; Pages: 3213
Cyber-physical systems (CPS) play an important role in the implementation of new Industry 4.0 solutions, acting as the backbone infrastructure to host distributed intelligence capabilities and promote the collective intelligence that emerges from the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::104eebb3ba266794cc99aff1deffe744
https://doi.org/10.3390/electronics11193213
https://doi.org/10.3390/electronics11193213
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 47(1)
Twenty-one patients underwent a drug-induced lymphocyte stimulation test(DLST)withanti -cancer drugs suspected as causative agents of allergy between January 1, 2013, and December 31, 2017, at Ichinomiya Municipal Hospital, and 7 (33.3%)and 14 patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1bce0182834997ba7920448a51551884
https://pubmed.ncbi.nlm.nih.gov/32381863
https://pubmed.ncbi.nlm.nih.gov/32381863
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 46(5)
We retrospectively investigated hypophosphatemia induced byty rosine kinase inhibitors(TKIs), in patients with chronic myeloid leukemia. Subjects evaluated were 14, 11, and 8 patients who received TKIs(imatinib, dasatinib and nilotinib), respectively
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::159d291771b8eb6a9e7cce63bd324403
https://pubmed.ncbi.nlm.nih.gov/31189810
https://pubmed.ncbi.nlm.nih.gov/31189810
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 45(9)
A man in his 50s with small cell lung cancer received amrubicin as the fourth-line therapy from August 201X-1. Serum phosphorus levels before treatment were normal at 2.9mg/dL, but grade 2 hypophosphatemia(2.1mg/dL)was observed at the beginning of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::87b4cc8d9628ecc6e056537467d3ad51
https://pubmed.ncbi.nlm.nih.gov/30237384
https://pubmed.ncbi.nlm.nih.gov/30237384
Autor:
Hiroaki, Sakurada, Miki, Aoi, Masaaki, Yuge, Yuriko, Sugimura, Kunio, Kitamura, Masumi, Yamamura, Tomoya, Tachi, Hitomi, Teramachi
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 43(7)
A 40's year-old female patient with acute myeloblastic leukemia received high-dose cytarabine(HD-Ara-C)as her third induction therapy. Because the pharmacist in charge noticed on a prior interview that she had experienced a mild skin eruption similar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e5da89def4895fee4bbcdc7450228863
https://pubmed.ncbi.nlm.nih.gov/27431642
https://pubmed.ncbi.nlm.nih.gov/27431642